Seizures occur more frequently in the neonatal period than in the remainder of childhood. Neonatal seizures can have different aetiologies. Inborn errors of metabolism are rare causes of seizures in the newborn. However, they are an important cause of intractable neonatal seizures, accounting for 30% of cases. Diagnosis is necessary for timely institution of appropriate treatment and is important in determining clinical outcome. As these are genetic conditions, it allows for appropriate genetic counselling. We describe the clinical presentation of neonatal seizures and the investigation findings in symptomatic neonatal seizures and epilepsy syndromes that arise in the neonatal period. The approach in diagnosis and investigation of an underlying inborn error of metabolism is described and inborn errors of metabolism that are important causes of neonatal seizures are reviewed.
ErganderUErikssonMZetterstromR. Severe neonatal asphyxia. Incidence and prediction of outcome in the Stockholm area. Acta Paediatr Scand. 1983;72(3):321–5.
2.
ErikssonMZetterstromR. Neonatal convulsions. Incidence and causes in the Stockholm area. Acta Paediatr Scand. 1979;68(6):807–11.
3.
SeayARBrayPF. Significance of seizures in infants weighing less than 2,500 grams. Arch Neurol. 1977;34(6):381–2.
4.
RonenGMPenneySAndrewsW. The epidemiology of clinical neonatal seizures in Newfoundland: A population-based study. J Pediatr. 1999;134(1):71–5.
5.
LanskaMJLanskaDJBaumannRJKryscioRJ. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology. 1995;45(4):724–32.
RoseALLombrosoCT. A study of clinical, pathological, and electroencephalographic features in 137 full-term babies with a long-term follow-up. Pediatrics. 1970;45(3):404–25.
8.
MizrahiEMKellawayP. Characterization and classification of neonatal seizures. Neurology. 1987;37(12):1837–44.
9.
BergABerkovicSFBrodieMJBuchhalterJRCrossJHvan Emde BoasW. Revised terminology and concepts for organization of the epilepsies: Report of the Commission on Classification and Terminology: ILAE, 2009.
10.
VolpeJJ. Neonatal seizures. In: VolpeJJ, editor. Neurology of the Newborn. 4th ed.Philadelphia: Saunders, 2001:178–214.
11.
TaeuschHWBallardRAGleasonCA. The Newborn Infant. Avery's Diseases of the Newborn. 8th ed: Elsevier-Saunders, 2005:1664 p.
12.
VisudhiphanPVisudtibhanAChiemchanyaSKhongkhatithumC. Neonatal seizures and familial hypomagnesemia with secondary hypocalcemia. Pediatr Neurol. 2005;33(3):202–5.
13.
WalderRYShalevHBrennanTMCarmiRElbedourKScottDA. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: Genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet. 1997;6(9):1491–7.
14.
PragaMVaraJGonzalez-ParraEAndresAAlamoCAraqueA. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int. 1995;47(5):1419–25.
15.
PlouinPAndersonVE. Benign familial and non-familial neonatal seizures. In: RogerJBureauMDravetCGentonPTassinariCAWolfP, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th Edition ed. Montrouge, France: John Libbey Eurotext, 2005:3–15.
YamatogiYOhtaharaS. Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases. Brain. Dev2002;24(1):13–23.
18.
ClarkeMGillJNoronhaMMcKinlayI. Early infantile epileptic encephalopathy with suppression burst: Ohtahara syndrome. Dev Med Child Neurol. 1987;29(4):520–8.
19.
HmaimessGRaftopoulosCKadhimHNassogneMCGharianiSde TourtchaninoffM. Impact of early hemispherotomy in a case of Ohtahara syndrome with left parieto-occipital megalencephaly. Seizure. 2005;14(6):439–42.
OhtsukaYSatoMSanadaSYoshinagaHOkaE. Suppression-burst patterns in intractable epilepsy with focal cortical dysplasia. Brain Dev. 2000;22(2):135–8.
22.
TrinkaERauscherCNaglerMMoroderTLadurnerGIrnbergerE. A case of Ohtahara syndrome with olivary-dentate dysplasia and agenesis of mamillary bodies. Epilepsia. 2001;42(7):950–3.
23.
WilliamsANGrayRGPoultonKRamaniPWhitehouseWP. A case of Ohtahara syndrome with cytochrome oxidase deficiency. Dev Med Child Neurol. 1998;40(8):568–70.
24.
AicardiJOhtaharaS. Severe neontal epilepsies with suppression-burst pattern. In: RogerJBureauMDravetCGentonPTassinariCAWolfP, editors. Epileptic syndromes in Infancy, Childhood and Adolescence. 4th Edition ed. Montrouge, France: John Libbey Eurotext, 2005:39–50.
BruelHBoullocheJChabrolleJPLayetVPoinsotJ. [Early myoclonic epileptic encephalopathy and nonketotic hyperglycemia in the same family]. Arch Pediatr. 1998;5(4):397–9.
DjukicALadoFAShinnarSMosheSL. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other?Epilepsy Res. 2006;70Suppl 1:S68–76.
29.
LeonardJVMorrisAA. Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatr2006;95(1):6–14.
30.
TharpBR. Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease. Pediatr Neurol. 1992;8(1):65–8.
31.
HoffmannCBen-ZeevBAniksterYNissenkornABrandNKuintJ. Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency. J Child Neurol. 2007;22(10):1214–21.
TanWHEichlerFSHodaSLeeMSBarisHHanleyCA. Isolated sulfite oxidase deficiency: A case report with a novel mutation and review of the literature. Pediatrics. 2005;116(3):757–66.
HayasakaKTadaKKikuchiGWinterSNyhanWL. Nonketotic hyperglycinemia: Two patients with primary defects of P-protein and T-protein, respectively, in the glycine cleavage system. Pediatr Res1983;17(12):967–70.
36.
KormanSHWexlerIDGutmanARollandMOKannoJKureS. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation. Ann Neurol. 2006;59(2):411–5.
37.
HamoshAMcDonaldJWValleDFrancomanoCANiedermeyerEJohnstonMV. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr. 1992;121(1):131–5.
38.
MortensenPBKplvraaSChristensenE. Inhibition of the glycine cleavage system: Hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia. 2007;21(6):563–69.
39.
TekgulHSerdarogluGKarapinarBPolatMYurtseverSTosunA. Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia. J Child Neurol. 2006;21(1):82–4.
40.
BaxterP. Pyridoxine dependent and pyridoxine responsive seizures. In: BaxterP, editor. Vitamin responsive conditions in paediatric neurology. London: Mac Keith Press, 2001:109–65.
41.
MillsPBStruysEJakobsCPleckoBBaxterPBaumgartnerM. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med. 2006;12(3):307–9.
42.
GospeSMJr. Neonatal vitamin-responsive epileptic encephalopathies. Chang Gung Med J. 2010;33(1):1–12.
43.
BaxterPGriffithsPKellyTGardner-MedwinD. Pyridoxine-dependent seizures: Demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol. 1996;38(11):998–1006.
44.
MikatiMATrevathanEKrishnamoorthyKSLombrosoCT. Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalography and Clinical Neurophysiology. 1991;78(3):215–21.
45.
HylandKBuistNRPowellBRHoffmanGFRatingDMcGrathJ. Folinic acid responsive seizures: A new syndrome?J Inherit Metab Dis. 1995;18(2):177–81.
46.
GallagherRCVan HoveJLScharerGHylandKPleckoBWatersPJ. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol. 2009;65(5):550–6.
47.
MillsPBSurteesRAChampionMPBeesleyCEDaltonNScamblerPJ. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet. 2005;14(8):1077–86.
ChenBCMcGownINThongMKPittJYunusZMKhooTB. Adenylosuccinate lyase deficiency in a Malaysian patient, with novel adenylosuccinate lyase gene mutations. J Inherit Metab Dis. 2010.
51.
JureckaAZikanovaMTylki-SzymanskaAKrijtJBogdanskaAGradowskaW. Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency. Mol Genet Metab. 2008;94(4):435–42.
52.
de KoningTJ. Treatment with amino acids in serine deficiency disorders. J Inherit Metab Dis. 2006;29(2–3): 347–51.
53.
PinedaMVilasecaMAArtuchRSantosSGarcía. 3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Developmental Medicine & Child Neurology. 2000;42(09):629–33.
54.
GireGire CGirardGirard NNicaiseNicaise C. Clinical features and neuroradiological findings of mitochondrial pathology in six neonates. Child's Nervous System. 2002;18(11):621–28.
55.
MorroneAMalvagiaSDonatiMAFunghiniSCianiFPelaI. Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency. Am J Med Genet. 2002;111(1):10–8.
56.
HaagerupAAndersenJBBlichfeldtSChristensenMF. Biotinidase deficiency: Two cases of very early presentation. Dev Med Child Neurol. 1997;39(12):832–5.
57.
TharpBR. Neonatal seizures and syndromes. Epilepsia. 2002;43Suppl 3:2–10.
58.
WangDPascualJMYangHEngelstadKJhungSSunRP. Glut-1 deficiency syndrome: Clinical, genetic, and therapeutic aspects. Ann Neurol. 2005;57(1):111–8.
59.
De VivoDCTrifilettiRRJacobsonRIRonenGMBehmandRAHarikSI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325(10):703–9.
60.
KlepperJVoitT. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: Impaired glucose transport into brain — a review. Eur J Pediatr. 2002;161(6):295–304.
